RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All EMA (EU) updates
EMA (EU)
EVENT
3Rs Working Party (3RsWP) stakeholder meeting - Public session on the 2026-2028 work plan
Published: 3/31/2026Detected: 3/26/2026

Summary preview

Presents the 3Rs Working Party (3RsWP) priorities and intended actions for 2026–2028 in a public stakeholder session, informing companies and other stakeholders of upcoming focus areas related to the 3Rs (Replace…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
manufacturing
quality
clinical
safety
labeling
infectious_disease
rare_diseases
pediatrics
oncology
cardiology

Official Source Document
Source Verified

Access the original document directly from EMA.

View Official Document

More from EMA (EU)

  • Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
  • Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
  • EMA annual call with General Practitioner Organisations' representatives11/20/2026
  • Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
  • Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026

Get EMA (EU) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
neurology
immunology
hematology
dermatology
psychiatry
gastroenterology
ophthalmology
respiratory
#3Rs
#Replace Reduce Refine
#EMA
#stakeholder engagement
#work plan
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.